Device type · LAF
Gas Chromatography, Methamphetamine
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
LAF
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Gas Chromatography, Methamphetamine
- Product code
- LAF
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3610
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LAF
Latest FDA decisions
K203647 · Decided Dec 22, 2021 · 373 days after receipt
Device type: Gas Chromatography, Methamphetamine (LAF) · Laboratory Medicine & Pathology
K210212 · Decided Dec 15, 2021 · 322 days after receipt
Device type: Gas Chromatography, Methamphetamine (LAF) · Laboratory Medicine & Pathology
K201442 · Decided Jul 31, 2020 · 60 days after receipt
Device type: Gas Chromatography, Methamphetamine (LAF) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1183-2021 · Started Feb 5, 2021
Reason given: Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate Reagent (TMB) lot 6679623, should not affect performance.
Cause as FDA categorized it: Packaging process control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.